User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

2309

Interactions with Platform & by Email *

INTERACTIONS

416

Unique # Participated *

PARTICIPANTS

69

Responses Validated *

VALIDATIONS

21

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
Angioplasty.....I-3
PTCA Devices.....I-3
PTCA Balloon Catheter.....I-3
  
   PTCA Guide Wires.....I-4
PTCA Guiding Catheters.....I-4
  
   Market Primer.....II-5
Current & Future Analysis.....II-5
Recession Decelerates Growth in PTCA Products Market.....II-5
1$100
   Rising Incidence and Prevalence of CHD – A Major Growth Driver.....II-6
Complexity of Older Angioplasty Procedures Drive the Development of Sophisticated Angioplasty Devices.....II-6
Vagaries Exist Among Adoption of Revascularization Procedures Worldwide.....II-6
1$100
   Table 1: Global Angioplasty Procedural Volume (2009-2012): Number of Procedures in Thousands for US, Japan and Rest of World (includes corresponding Graph/Chart).....II-7
Angioplasty versus CABG – The Debate on the Most Effective Procedure Continues.....II-7
1$350
   Drug-Eluting Balloons (DEBs) – A New Advancement in Intravascular Procedures.....II-8
Few Products on the Market, Many More to Come.....II-8
1$100
   Select Marketed and Development-Stage Drug-Eluting Balloon Products.....II-9
Expanded Applications to Fortify Demand for Drug Eluting Balloons.....II-9
1$100
   Peripheral Arterial Disease Augurs More Prospects for Drug-Eluting Balloons.....II-10
Promise of Major Benefits Draws Widespread Interest.....II-10
Drug-Eluting Balloons – A Threat to Drug-Eluting Stents in Coronary Procedures?.....II-10
1$100
   Safety Concerns on Drug-Eluting Stents Open Window of Opportunity for Drug-Eluting Balloons.....II-11
Paclitaxel Remains the Most Sought-After Drug for DEBs.....II-11
1$100
   Boston Scientific Corp. – A Leading Global Player in the Angioplasty Market.....II-12
Bard Fortifies Market Share, Eyes No. 1 Spot in Peripheral PTA Market.....II-12
1$100
   Stent – A Key Support Device in Angioplasty.....II-13
Concerns over Restenosis Post-Angioplasty Drives Use of Stents.....II-13
Stents – Types and Application.....II-13
A Peek into Peripheral Vascular Stents Market.....II-13
1$100
   Lack of Awareness Limits Growth.....II-14
Table 2: Global Peripheral Vascular Stents Market by Region: Percentage Breakdown of Revenues for US, Europe, and Asia-Pacific (includes corresponding Graph/Chart).....II-14
Coronary Stents Market – An Overview.....II-14
1$350
   Aging Population, New Technologies to Boost Market for Coronary Stents.....II-15
Table 3: Global Coronary Stents Market by Region: Percentage Breakdown of Revenues for Europe, US, Asia-Pacific, and Rest of World (includes corresponding Graph/Chart).....II-15
A Brief Insight into the Drug Eluting Stents Market.....II-15
1$350
   Table 4: Global Drug-Eluting Stents Market by Product Type (2010): Percentage Breakdown of Unit Sales and Revenues for Coronary Stents and Others (includes corresponding Graph/Chart).....II-16
Concerns Over Safety and Cost Restrain Adoption of DES.....II-16
1$350
   Intensifying Competition in the DES Space.....II-17
Table 5: Global Drug-Eluting Stents Market (2009-2012): Market Share Breakdown of Value Sales for Abbott Laboratories, Boston Scientific, Medtronic, Johnson & Johnson and Others (includes corresponding Graph/Chart).....II-17
1$350
   Introduction.....II-18
What Can Angioplasty Do?.....II-18
An Overview of Angioplasty Procedure.....II-18
1$100
   Types of Angioplasty Procedures.....II-19
Balloon Angioplasty.....II-19
Advantages of Angioplasty.....II-19
1$100
   Major Disadvantages.....II-20
Stenting.....II-20
Laser Angioplasty.....II-20
Atherectomy.....II-20
1$100
   Cutting Balloon.....II-21
Limitations of the Angioplasty Procedure.....II-21
Risk Factors in Angioplasty Procedures.....II-21
Balloon Angioplasty Devices.....II-21
Balloon Catheters.....II-21
1$100
   Guide Wires.....II-22
Guiding Catheters.....II-22
1$100
   Boston Scientific to Launch Mustang PTA Balloon Catheter.....II-23
Eurocor Introduces New PTA Balloon Technology.....II-23
1$100
   Boston Scientific Introduces Sterling SL Balloon Catheter for Treating PAD.....II-24
Boston Scientific Rolls out Journey Guidewire for Peripheral Angioplasty Procedures.....II-24
Volcano to Launch Three Products in the US.....II-24
TRT and NovaRay Medical Develop X-Ray Imaging System with Nethra's MPPA Devices.....II-24
1$100
   Abbott Introduces Omnilink® Elite Peripheral Stent System.....II-25
Invatec Launches FiberNet®.....II-25
Cook Medical Launches Zilver PTX Drug-Eluting Peripheral Stent.....II-25
Abbott Unveils FoxCross™ PTA Catheter and HI-TORQUE Versacore™ Guide Wire.....II-25
1$100
   Invatec Unveils Tapered and Amphirion Balloons.....II-26
Abbott Introduces VOYAGER™ NC Coronary Dilatation Catheter.....II-26
1$100
   Vascumed Introduces DIOR Paclitaxel-Coated Coronary Balloon Dilatation Catheter.....II-27
Invatec Introduces IN.PACT Amphirion Paclitaxel-eluting PTA Balloon Catheter.....II-27
Cook Medical Introduces New Products for PAD Treatment.....II-27
1$100
   Terumo Introduces Glidewire Advantage™ Peripheral Guide Wire.....II-28
Cook Medical Unveils Advance PTX Balloon.....II-28
Medtronic Launches Angioplasty Products on Rapid Exchange Delivery System.....II-28
1$100
   Cordis Launches SLEEK™ and SAVVY® Long PTA Balloon Dilatation Catheters.....II-29
B. Braun Introduces SeQuent Please in Malaysia.....II-29
Cook Medical Rolls Out Advance® 18LP PTA Balloon Dilatation Catheter in North America.....II-29
1$100
   Invatec Releases REEF HP™ PTA Balloon Catheter in Europe.....II-301$100
   FDA Rejects Angioplasty Test of Nanosphere.....II-31
Terumo Corporation Signs Supply Agreement with Kaneka Subsidiary.....II-31
Asahi Intecc and Terumo Join Hands to Develop Medical Guidewire.....II-31
Hotspur Secures FDA Approval for its First Three Commercial Products.....II-31
1$100
   Angioslide Secures FDA Clearance for eXtra Angioplasty Balloon Catheter.....II-32
Opto Circuits Receives European Approval for Marketing Drug Eluting Stent.....II-32
Volcano Enters into Distribution Agreement with AngioScore.....II-32
Volcano Acquires Xtract™ Thrombus Range from Lumen Biomedical.....II-32
1$100
   Boston Scientific Obtains FDA Approval for NC Quantum Apex Balloon Catheter.....II-33
Medtronic Acquires Invatec and Associated Companies.....II-33
Avinger Merges with Sawtooth Labs.....II-33
Medrad and B Braun Sign Co-Marketing and Trademark License Agreement.....II-33
1$100
   Invatec and Cardiovascular Systems Sign Strategic Distribution Agreement.....II-34
ClearStream Obtains Approval for Marketing Peripheral Angioplasty Balloon.....II-34
AngioScore Receives Approval for AngioSculpt in Japan.....II-34
Minnow Medical Obtains Approval for Disposable Catheter.....II-34
1$100
   MAQUET’ MEGA™ Intra-Aortic Balloon Catheter Receives CE Mark.....II-35
FDA Grants Clearance to Cook’s Advance® 35LP PTA Balloon Dilation Catheter.....II-35
Invatec Obtains CE Mark for IN.PACT™ Admiral Drug Eluting Balloon Catheter.....II-35
1$100
   Invatec Receives CE Mark for IN.PACT Falcon Paclitaxel-Eluting PTCA Balloon Catheter.....II-361$100
   Abbott Vascular (US).....II-37
Boston Scientific Corporation (US).....II-37
1$100
   C. R. Bard, Inc. (US).....II-38
Cordis Corporation (US).....II-38
1$100
   Goodman Co., Ltd. (Japan).....II-39
Medtronic, Inc. (US).....II-39
1$100
   Terumo Corporation (Japan).....II-401$100
   Table 6: World Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-411$350
   Table 7: World Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-421$350
   Table 8: World 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-431$350
   Table 9: World Recent Past, Current, and Future Analysis for PTCA Balloon Catheters by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-441$350
   Table 10: World Historic Review for PTCA Balloon Catheters by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-451$350
   Table 11: World 15-Year Perspective for PTCA Balloon Catheters by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-461$350
   Table 12: World Recent Past, Current, and Future Analysis for PTCA Guiding Catheters by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-471$350
   Table 13: World Historic Review for PTCA Guiding Catheters by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-481$350
   Table 14: World 15-Year Perspective for PTCA Guiding Catheters by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-491$350
   Table 15: World Recent Past, Current, and Future Analysis for PTCA Guide Wires by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-501$350
   Table 16: World Historic Review for PTCA Guide Wires by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Independently Analyzed with Annual Sales in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-511$350
   Table 17: World 15-Year Perspective for PTCA Guide Wires by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-521$350
   A. Market Analysis.....II-53
Coronary Heart Disease – A Leading Cause of Mortality in the US.....II-53
Angioplasty – The Most Opted Procedure for Treating CHD in the US.....II-53
1$100
   Table 18: US Angioplasty Procedural Volume in Thousands: 2009-2012 (includes corresponding Graph/Chart).....II-54
Angioplasty – More Beneficial in Acute Cases.....II-54
Peripheral Interventional Market Trails High Growth.....II-54
1$350
   FDA Reclassifies PTCA Device Status and Drafts Guidance.....II-551$100
   Market Snippets.....II-56
Table 19: US Drug-Eluting Stents Market (2009-2012): Market Share Breakdown of Value Sales for Boston Scientific, Abbott Laboratories, Medtronic, and Johnson & Johnson (includes corresponding Graph/Chart).....II-56
Product Launches.....II-56
5$350
   Strategic Corporate Developments.....II-612$125
   Focus on Select Key Players.....II-634$225
   B. Market Analytics.....II-67
Table 20: The US Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-67
1$350
   Table 21: The US Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-681$350
   Table 22: The US 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-691$350
   A. Market Analysis.....II-70
Angioplasty Procedural Volume Rises in Canada.....II-70
Improved Access to Angioplasty Centers in Canada.....II-70
1$100
   Angioplasty Procedural Costs in Canada – A Recent Past Review.....II-71
Table 23: Snowballing Effect of Cost Factors on Angioplasty Hospital Costs in Canada: 2005-2006 (includes corresponding Graph/Chart).....II-71
1$350
   Voices Against Extensive Use of Angioplasty Echo in Canada.....II-721$100
   B. Market Analytics.....II-73
Table 24: Canadian Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-73
1$350
   Table 25: Canadian Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-741$350
   Table 26: Canadian 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-751$350
   A. Market Analysis.....II-76
Government’s Efforts to Curb Prices of IC Devices.....II-76
Simplified Regulations and Indication Specific Approvals Bring Pace in Peripheral Vascular Stent Market.....II-76
1$100
   Competitive Landscape.....II-77
Terumo Leads Japanese PTCA Balloon Catheter Market.....II-77
Competition in Japanese Drug-Eluting Stents Market.....II-77
Table 27: Japanese Drug-Eluting Stents Market (2009-2012): Market Share Breakdown of Value Sales for Abbott Laboratories, Boston Scientific, Medtronic, Johnson & Johnson and Others (includes corresponding Graph/Chart).....II-77
1$350
   Product Launch.....II-78
Strategic Corporate Developments.....II-78
1$100
   Focus on Select Key Players.....II-791$100
   B. Market Analytics.....II-80
Table 28: Japanese Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-80
1$350
   Table 29: Japanese Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-811$350
   Table 30: Japanese 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-821$350
   A. Market Analysis.....II-83
CHD In Europe – An Overview on Disease Statistics.....II-83
Demographic Factors Boost Market Growth.....II-83
1$100
   Inconsistency in Drug-Eluting Balloon Approval Procedure Beleaguers Manufacturers.....II-84
Product Launches.....II-84
1$100
   Strategic Corporate Developments.....II-853$175
   B. Market Analytics.....II-88
Table 31: European Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-88
1$350
   Table 32: European Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-891$350
   Table 33: European 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-901$350
   Table 34: European Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-911$350
   Table 35: European Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-921$350
   Table 36: European 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-931$350
   Market Analysis.....II-94
Table 37: French Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-94
1$350
   Table 38: French Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-951$350
   Table 39: French 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-961$350
   A. Market Analysis.....II-97
Product Launch.....II-97
Strategic Corporate Development.....II-97
1$100
   B. Market Analytics.....II-98
Table 40: German Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-98
1$350
   Table 41: German Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-991$350
   Table 42: German 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-1001$350
   Market Analysis.....II-101
Table 43: Italian Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-101
1$350
   Table 44: Italian Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-1021$350
   Table 45: Italian 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-1031$350
   A. Market Analysis.....II-104
Increasing Popularity of Angioplasty Procedures through Radial Artery.....II-104
CHD – A Menacing Disease in the UK.....II-104
1$100
   Table 46: Number of People Affected with CHD in the UK by Country: 2008-2009 (includes corresponding Graph/Chart).....II-105

Table 47: Prevalence of CHD in England by Age Group and Gender (2006) (includes corresponding Graph/Chart).....II-105
CHD Related Mortality on the Decline.....II-105
1$350
   Product Launch.....II-1061$100
   B. Market Analytics.....II-107
Table 48: The UK Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-107
1$350
   Table 49: The UK Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-1081$350
   Table 50: The UK 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-1091$350
   Market Analysis.....II-110
Market Analysis.....II-110
1$100
   Table 51: Rest of European Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-1111$350
   Table 52: Rest of European Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-1121$350
   Table 53: Rest of European 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-1131$350
   A. Market Analysis.....II-114
Rising Demand for Angioplasty Devices in China.....II-114
1$100
   Table 54: Unit Sales of PTCA Balloon Catheters in China by Type (2005-2009) (includes corresponding Graph/Chart).....II-115
Foreign Companies Continue to Dominate Chinese PTCA Balloon Market.....II-115
CHD in Australia – An Overview of Disease Statistics in the Country.....II-115
1$350
   Strong Growth Ahead for IC Devices.....II-116
Product Launch.....II-116
1$100
   Strategic Corporate Development.....II-117
B. Market Analytics.....II-117
Table 55: Asia-Pacific Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-117
1$350
   Table 56: Asia-Pacific Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-1181$350
   Table 57: Asia-Pacific 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-1191$350
   A. Market Analysis.....II-120
Steady Growth Ahead for Latin American IC Devices Market.....II-120
Brazilian DES Market Suffers Due to Non-Reimbursement Policy in Public Healthcare System.....II-120
1$100
   B. Market Analytics.....II-121
Table 58: Latin American Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-121
1$350
   Table 59: Latin American Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-1221$350
   Table 60: Latin American 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-1231$350
   Market Analysis.....II-124
Table 61: Rest of World Recent Past, Current, and Future Analysis for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-124
1$350
   Table 62: Rest of World Historic Review for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Balloon Catheters, Guiding Catheters, and Guide Wires Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-1251$350
   Table 63: Rest of World 15-Year Perspective for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products by Product Type - Percentage Breakdown of Dollar Sales for Balloon Catheters, Guiding Catheters, and Guide Wires Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-1261$350
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com